Always-On Experimentation
Abstract
Generative AI has dramatically accelerated the rate at which new treatments---from novel pharmaceuticals to online marketing campaigns---can be conceived and deployed. As a result, modern experimentation platforms often run continuously, with treatments added as they are ready and removed when they underperform. We formalize this "Always-On" experimental setting, in which treatments can be dynamically generated, added to, and removed from a running experiment, and study the statistical problem of deciding whether to accept or reject each treatment while controlling for the false discovery rate. We develop sequential tests that achieve time-uniform Type-I error control under arbitrary stopping times and "predictable" treatment schedules. Our approach builds on the testing-by-betting framework: we construct test supermartingales for testing the average treatment effect of each treatment, and show that the construction of these test supermartingales is growth-rate optimal in an almost-sure sense.
Related
- Un module universitaire de type « capstone course » en arithmétique – une pré-expérimentation
- Atomic Leontievian Cournotian traders are always Walrasian
- The product of two Scott sober complete lattices is not always Scott sober
- Principal-agent hypothesis testing under adaptive experimentation
- The entropy production is not always monotone for hard spheres or for Maxwell molecules
BibTeX
@misc{sandoval2026alwayson,
title = {{Always-On Experimentation}},
author = {Ricardo J. Sandoval and David Arbour and Avi Feller and Michael I. Jordan},
howpublished = {arXiv},
year = {2026},
month = sep,
doi = {10.48550/arxiv.2609.38695},
eprint = {2609.38695},
archivePrefix = {arXiv},
url = {https://arxiv.org/abs/2609.38695},
}
RIS
TY - UNPB
TI - Always-On Experimentation
AU - Ricardo J. Sandoval
AU - David Arbour
AU - Avi Feller
AU - Michael I. Jordan
PY - 2026
DA - 2026/09/30
PB - arXiv
DO - 10.48550/arxiv.2609.38695
UR - https://arxiv.org/abs/2609.38695
AB - Generative AI has dramatically accelerated the rate at which new treatments---from novel pharmaceuticals to online marketing campaigns---can be conceived and deployed. As a result, modern experimentation platforms often run continuously, with treatments added as they are ready and removed when they underperform. We formalize this "Always-On" experimental setting, in which treatments can be dynamically generated, added to, and removed from a running experiment, and study the statistical problem of deciding whether to accept or reject each treatment while controlling for the false discovery rate. We develop sequential tests that achieve time-uniform Type-I error control under arbitrary stopping times and "predictable" treatment schedules. Our approach builds on the testing-by-betting framework: we construct test supermartingales for testing the average treatment effect of each treatment, and show that the construction of these test supermartingales is growth-rate optimal in an almost-sure sense.
ER -